274 related articles for article (PubMed ID: 26169403)
1. Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora.
Blount KF; Megyola C; Plummer M; Osterman D; O'Connell T; Aristoff P; Quinn C; Chrusciel RA; Poel TJ; Schostarez HJ; Stewart CA; Walker DP; Wuts PG; Breaker RR
Antimicrob Agents Chemother; 2015 Sep; 59(9):5736-46. PubMed ID: 26169403
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the mechanism of action of 5FDQD and the design of new neutral analogues for the FMN riboswitch: a well-tempered metadynamics simulation study.
Wakchaure PD; Ganguly B
Phys Chem Chem Phys; 2022 Jan; 24(2):817-828. PubMed ID: 34928280
[TBL] [Abstract][Full Text] [Related]
3. Structure-Activity Relationship of Flavin Analogues That Target the Flavin Mononucleotide Riboswitch.
Vicens Q; Mondragón E; Reyes FE; Coish P; Aristoff P; Berman J; Kaur H; Kells KW; Wickens P; Wilson J; Gadwood RC; Schostarez HJ; Suto RK; Blount KF; Batey RT
ACS Chem Biol; 2018 Oct; 13(10):2908-2919. PubMed ID: 30107111
[TBL] [Abstract][Full Text] [Related]
4. Rare variants of the FMN riboswitch class in
Atilho RM; Perkins KR; Breaker RR
RNA; 2019 Jan; 25(1):23-34. PubMed ID: 30287481
[TBL] [Abstract][Full Text] [Related]
5. Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting.
Wang H; Mann PA; Xiao L; Gill C; Galgoci AM; Howe JA; Villafania A; Barbieri CM; Malinverni JC; Sher X; Mayhood T; McCurry MD; Murgolo N; Flattery A; Mack M; Roemer T
Cell Chem Biol; 2017 May; 24(5):576-588.e6. PubMed ID: 28434876
[TBL] [Abstract][Full Text] [Related]
6. Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.
Theriot CM; Schumacher CA; Bassis CM; Seekatz AM; Young VB
Antimicrob Agents Chemother; 2015 Mar; 59(3):1596-604. PubMed ID: 25547352
[TBL] [Abstract][Full Text] [Related]
7. Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression.
Lee ER; Blount KF; Breaker RR
RNA Biol; 2009; 6(2):187-94. PubMed ID: 19246992
[TBL] [Abstract][Full Text] [Related]
8. Bacterial flavin mononucleotide riboswitches as targets for flavin analogs.
Pedrolli DB; Mack M
Methods Mol Biol; 2014; 1103():165-76. PubMed ID: 24318894
[TBL] [Abstract][Full Text] [Related]
9. Purine analogs targeting the guanine riboswitch as potential antibiotics against Clostridioides difficile.
Yan LH; Le Roux A; Boyapelly K; Lamontagne AM; Archambault MA; Picard-Jean F; Lalonde-Seguin D; St-Pierre E; Najmanovich RJ; Fortier LC; Lafontaine D; Marsault É
Eur J Med Chem; 2018 Jan; 143():755-768. PubMed ID: 29220796
[TBL] [Abstract][Full Text] [Related]
10. The riboflavin analog roseoflavin targets an FMN-riboswitch and blocks Listeria monocytogenes growth, but also stimulates virulence gene-expression and infection.
Mansjö M; Johansson J
RNA Biol; 2011; 8(4):674-80. PubMed ID: 21593602
[TBL] [Abstract][Full Text] [Related]
11. Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic.
Sears P; Ichikawa Y; Ruiz N; Gorbach S
Ann N Y Acad Sci; 2013 Jul; 1291():33-41. PubMed ID: 23672600
[TBL] [Abstract][Full Text] [Related]
12. Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
Lv Z; Peng G; Liu W; Xu H; Su J
Antimicrob Agents Chemother; 2015 Jul; 59(7):3726-35. PubMed ID: 25824219
[TBL] [Abstract][Full Text] [Related]
13. A dual control mechanism synchronizes riboflavin and sulphur metabolism in Bacillus subtilis.
Pedrolli DB; Kühm C; Sévin DC; Vockenhuber MP; Sauer U; Suess B; Mack M
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):14054-9. PubMed ID: 26494285
[TBL] [Abstract][Full Text] [Related]
14. A highly specialized flavin mononucleotide riboswitch responds differently to similar ligands and confers roseoflavin resistance to Streptomyces davawensis.
Pedrolli DB; Matern A; Wang J; Ester M; Siedler K; Breaker R; Mack M
Nucleic Acids Res; 2012 Sep; 40(17):8662-73. PubMed ID: 22740651
[TBL] [Abstract][Full Text] [Related]
15. Bis-Cyclic Guanidines as a Novel Class of Compounds Potent against Clostridium difficile.
Li C; Teng P; Peng Z; Sang P; Sun X; Cai J
ChemMedChem; 2018 Jul; 13(14):1414-1420. PubMed ID: 29768720
[TBL] [Abstract][Full Text] [Related]
16. The ribB FMN riboswitch from Escherichia coli operates at the transcriptional and translational level and regulates riboflavin biosynthesis.
Pedrolli D; Langer S; Hobl B; Schwarz J; Hashimoto M; Mack M
FEBS J; 2015 Aug; 282(16):3230-42. PubMed ID: 25661987
[TBL] [Abstract][Full Text] [Related]
17. Validation and Development of an Escherichia coli Riboflavin Pathway Phenotypic Screen Hit as a Small-Molecule Ligand of the Flavin Mononucleotide Riboswitch.
Balibar CJ; Villafania A; Barbieri CM; Murgolo N; Roemer T; Wang H; Howe JA
Methods Mol Biol; 2018; 1787():19-40. PubMed ID: 29736707
[TBL] [Abstract][Full Text] [Related]
18. [Antimicrobial activity of oral quinolones against clinical isolates of Bifidobacterium group and Clostridium difficile].
Kimura M; Yamagishi Y; Terada M; Ohki E; Tanaka K; Watanabe K; Mikamo H
Jpn J Antibiot; 2010 Apr; 63(2):171-7. PubMed ID: 20919497
[TBL] [Abstract][Full Text] [Related]
19. Tigecycline for the treatment of severe Clostridium difficile infection.
Larson KC; Belliveau PP; Spooner LM
Ann Pharmacother; 2011 Jul; 45(7-8):1005-10. PubMed ID: 21730279
[TBL] [Abstract][Full Text] [Related]
20. Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice.
Pultz NJ; Donskey CJ
Antimicrob Agents Chemother; 2005 Aug; 49(8):3529-32. PubMed ID: 16048976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
